America Drug Safety & AI Conference 2026
A conference on applying AI in pharmacovigilance, including validation, regulation, and workforce implications.
- Date
- December 2, 2026
- City
- San Diego
TL;DR
- The 2026 conference begins December 2 in San Diego.
- Its subject is the use and oversight of AI in pharmacovigilance, including system validation and the interpretation of AI-generated safety signals.
- The program also addresses changes to PV roles, reskilling, and concerns about bias and representation.
Who you'll find in the room
Drug safety & Pharmacovigilance executives
Heads of global safety programs
AI, ML and LLM
Digitalisation
Data
Innovation
Quantitative Analysis
QPPVs
Benefit-Risk assessment management
Medical affairs management
Patient safety management
Compliance specialists
Post-market researchers
PV auditors
Regulatory affairs directors
Pharma IT management
Safety consultants
Featured speakers
8 listedLalitha Aiyer
Szczepan Baran
Piet Vervaet
Kate Gofman
Aparna Ahuja
Lian Li
Monica Jain
Subhayan Das
Questions people ask
5 answeredIt begins on December 2, 2026.
The 2026 conference is held in San Diego.
The organizer lists drug safety and pharmacovigilance executives, global safety program leaders, QPPVs, regulatory affairs directors, and other specialists across safety, compliance, data, and technology.
Clinicians or safety staff looking for hands-on case-processing training would get less from it, because the stated focus is strategy, workforce change and ethics around AI rather than operational technique.
Attendees at pharma drug safety conferences usually wear business casual to business formal, such as slacks and a blazer or a collared shirt.
Related events
Find more events with this kind of reach.
We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.
Also listed in